Paper: Co. knew of drug - liver link
Warner-Lambert Co. downplayed liver damage concerns as it sought federal approval for its diabetes drug Rezulin, the Los Angeles Times reported Sunday. Warner-Lambert assured the U.S. Food and Drug
Warner-Lambert Co. downplayed liver damage concerns as it sought federal approval for its diabetes drug Rezulin, the Los Angeles Times reported Sunday. Warner-Lambert assured the U.S. Food and Drug